PTEN and neoplasm: miR-370 targeted FoxM1 functions as a tumor suppressor in LSCC [35]; miR-1290 acts as a novel potential oncomiR in LSCC [36]; miR-1297 mediates PTEN expression and contributes to LSCC cell progression [37].